M&A · Healthcare · Pharmaceutical Preparations
Avenue Therapeutics, Inc. to acquire Axsome Therapeutics, Inc.
Announced Nov 6, 2025 · Announced
Deal value—
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationNot disclosed
Transaction
- Acquirer
- Avenue Therapeutics, Inc. (ATXI)
- Target
- Axsome Therapeutics, Inc. (AXSM)
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- —
- Status
- Announced
Deal protections
Not yet read from the merger agreement.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Sector context · Healthcare
- Comparable deals
- 96 in the prior 24 months
- Premium
- Sector median 59.5%
- EV / Adj. EBITDA
- Sector median 14.5x
- Break fee
- Sector median 3.4%
Timeline
- AnnouncedNov 6, 2025
- ClosedPending